References

The end of AIDS: HIV infection as a chronic disease

10.1016/s0140-6736(13)61809-7 · 2013 · External reference

Human immunodeficiency virus as a risk factor for cardiovascular disease

10.1007/s12012-023-09815-4 · 2024 · External reference

PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in England

10.1136/bmjopen-2018-025497 · 2019 · External reference

Prevalence and risk of subclinical carotid atherosclerosis in the global population with HIV: a systematic review and meta-analysis

10.1177/0956462420972854 · 2021 · External reference

Menopause: an opportunity to optimize health and well being for people with HIV.

10.1097/coh.0000000000000944 · 2025 · External reference

Progression of metabolic syndrome severity during the menopausal transition

10.1161/jaha.116.003609 · 2016 · External reference

Menopause and the metabolic syndrome: the study of women’s health across the nation

10.1001/archinte.168.14.1568 · 2008 · External reference

A meta-analysis of the metabolic syndrome prevalence in the global HIV-infected population

10.1371/journal.pone.0150970 · 2016 · External reference

Metabolic syndrome in HIV-infected middle-aged women on antiretroviral therapy: prevalence and associated factors

10.1016/j.bjid.2017.02.003 · 2017 · External reference

Cardiovascular risk in HIV-infected individuals: a comparison of three risk prediction algorithms

10.1016/j.repc.2019.08.002 · 2019 · External reference

Subclinical atherosclerosis across the menopausal transition in women with and without HIV

10.1093/infdis/jiad488 · 2024 · External reference

Cardiovascular risk prediction functions underestimate risk in HIV infection

10.1161/circulationaha.117.028975 · 2018 · External reference

Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population

10.1111/hiv.13124 · 2021 · External reference

The data-collection on adverse effects of anti-HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV

10.1111/hiv.13147 · 2021 · External reference

Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models

10.1111/hiv.12300 · 2016 · External reference

HIV infection and carotid artery intima-media thickness: pooled analyses across 5 cohorts of the NHLBI HIV-CVD Collaborative

10.1093/cid/ciw261 · 2016 · External reference

Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations

10.1111/hiv.13093 · 2021 · External reference

Cardiovascular risk in HIV-infected and uninfected postmenopausal minority women: use of the Framingham risk score

10.1089/jwh.2015.5736 · 2017 · External reference

Brazilian guidelines of hypertension—2020

10.36660/abc.20201238 · 2021 · External reference

ASE consensus statement.

10.1016/j.echo.2007.11.011 · 2008 · External reference

Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose

2017 · External reference

Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation

10.1111/j.1464-5491.2006.01858.x · 2006 · External reference

2. Diagnosis and classification of diabetes: standards of care in diabetes—2024

2024 · External reference

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

10.1161/circulationaha.107.699579 · 2008 · External reference

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the data-collection on adverse effects of anti-HIV drugs (D:A:D) study

10.1177/2047487315579291 · 2016 · External reference

High concordance between D:A:Dr and the Framingham Risk Score in Brazilians living with HIV

10.3390/v15020348 · 2023 · External reference

Bone mass, fracture risk, and associated factors in postmenopausal women living with HIV

10.1097/gme.0000000000002293 · 2024 · External reference

Factors associated with worse cerebrovascular function in aging women with and at risk for HIV

10.1097/qad.0000000000002755 · 2021 · External reference

Aging with HIV in Latin America and the Caribbean: a systematic review

10.1007/s11904-020-00538-7 · 2021 · External reference

Levels and correlates of physical activity and capacity among HIV-infected compared to HIV-uninfected individuals

10.1371/journal.pone.0262298 · 2022 · External reference

Cotidiano de mulheres após contágio pelo HIV/aids: subsídios norteadores da assistência de enfermagem

10.1590/s0104-07072013000200009 · 2013 · External reference

HIV and menopause: a review

10.1089/jwh.2007.0345 · 2007 · External reference

Higher cardiovascular disease risks in people living with HIV: a systematic review and meta-analysis

10.7189/jogh.14.04078 · 2024 · External reference

HIV, Combination antiretroviral therapy, and vascular diseases in men and women

10.1016/j.jacbts.2021.10.017 · 2022 · External reference

The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV

2023 · External reference

HIV and cardiovascular disease: update on clinical events, special populations, and novel biomarkers

10.1007/s11904-018-0400-5 · 2018 · External reference

T cell activation predicts carotid artery stiffness among HIV-infected women

10.1016/j.atherosclerosis.2011.03.011 · 2011 · External reference

Antiretroviral therapy and cardiovascular risk in people with HIV • OFID • 1 antiretroviral therapy and cardiovascular risk in people with HIV in the United States—an updated analysis

10.1093/ofid/ofae485 · 2024 · External reference

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging

10.1097/gme.0b013e31824d8f40 · 2012 · External reference